Statement Of Cash Flows [Abstract]

Carl Zeiss Meditec AG - Filing #6472612

Concept 2023-10-01 to
2024-09-30
2022-10-01 to
2023-09-30
Statement of cash flows [abstract]
Cash flows from (used in) operating activities [abstract]
Adjustments for decrease (increase) in trade and other receivables
21,616 EUR
21,178 EUR
Adjustments for decrease (increase) in other assets
41,476 EUR
9,699 EUR
Adjustments for increase (decrease) in other liabilities
6,659 EUR
17,238 EUR
Cash flows from (used in) investing activities [abstract]
Proceeds from disposals of property, plant and equipment, intangible assets other than goodwill, investment property and other non-current assets
66,000 EUR
355,000 EUR
Cash flows from (used in) financing activities [abstract]
Dividends paid to equity holders of parent, classified as financing activities
98,204 EUR
98,385 EUR
Dividends paid to non-controlling interests, classified as financing activities
0 EUR
2,194 EUR
Cash flows from (used in) increase (decrease) in current borrowings
206,000 EUR
8,000 EUR

Talk to a Data Expert

Have a question? We'll get back to you promptly.